Osteonecrosis of the jaws in newly diagnosed multiple myeloma patients treated with zoledronic acid and thalidomide-dexamethasone
about
Bisphosphonates in multiple myeloma: a network meta-analysisBisphosphonates in multiple myelomaBisphosphonates: mechanism of action and role in clinical practiceDiagnosis and treatment of bone disease in multiple myeloma: spotlight on spinal involvementBisphosphonate-related osteonecrosis of the jaw: historical, ethical, and legal issues associated with prescribing.Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patientsPotential pathophysiological mechanisms in osteonecrosis of the jaw.The "CROMa" Project: A Care Pathway for Clinical Management of Patients with Bisphosphonate Exposure.Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw.Bisphosphonate-induced osteonecrosis of the jaw.Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonatesBiphosphonates-related osteonecrosis of the jaw: Clinical and physiopathological considerations.Osteonecrosis of the myeloma patients treated with bisphosphonates.Prevention of bisphosphonates-induced osteonecrosis.Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients.A review of the clinical implications of bisphosphonates in dentistry.Zoledronic acid in the management of bone disease as a consequence of multiple myeloma: a review.¹⁸F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders.Bisphosphonates in multiple myeloma: an updated network meta-analysis.Osteonecrosis of the Jaws (ONJ) after Bisphosphonate Treatment in Patients with Multiple Myeloma: Decreasing ONJ Incidence after Adoption of Preventive Measures.Prevalence of Medication-Related Osteonecrosis of the Jaw in Patients with Breast Cancer, Prostate Cancer, and Multiple Myeloma.
P2860
Q24197839-ACAEBB1D-E45D-424B-85EA-4A3FE8AE94E0Q24236776-46DFBFC9-D52F-49AF-A50A-82C52FC86C2EQ24644708-C16EE2BE-F2E9-4A89-B7D7-22625CBF8213Q27011865-D945D795-E563-441D-AF19-904CBC2E821EQ33885770-2442F28D-43AF-4E1C-8485-0EFCD592DFE1Q34031441-9EE3785A-4633-4DF5-BA0F-BA093480310FQ34162359-5377C80D-A452-41E1-BCCC-5C49B7F6A39EQ34307471-984B49CE-AD38-4160-97C3-ED4E419E0EAAQ35584343-6B044BF3-133C-468A-A884-27FCFCC34366Q36735192-42D9D8FC-920A-4B0A-8FDA-9E69A397ACE0Q37179393-B78011A0-422C-46D3-9D72-FCDD65A81785Q37230315-A4AC7458-98AF-4260-82A3-33223A5D0012Q37430240-91AADBDC-EF8F-4668-ADBA-D19A7DA0B586Q37430252-89EB4538-93D2-494D-8601-AAAFC5EF892FQ37800176-4E7A77B0-41E0-4CE9-8339-8AF81BA6DF51Q37844656-836269A1-FF48-4969-88F7-F37A5AC63452Q38170525-96997F8B-D8FE-45A7-A29B-04E9229C2500Q38248907-DCCE5349-53F4-444B-9687-7EF57146B96CQ47290135-DDF9329F-7C87-4AEA-AC4F-07CF906AAF4FQ55346257-7F64550A-A7B1-40B3-8DEB-31CE295904ABQ55384058-4A9F0FE0-E48D-499C-AB56-B6BDC9046785
P2860
Osteonecrosis of the jaws in newly diagnosed multiple myeloma patients treated with zoledronic acid and thalidomide-dexamethasone
description
im Dezember 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 December 2006
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2006
@uk
name
Osteonecrosis of the jaws in n ...... and thalidomide-dexamethasone
@en
Osteonecrosis of the jaws in n ...... and thalidomide-dexamethasone
@nl
type
label
Osteonecrosis of the jaws in n ...... and thalidomide-dexamethasone
@en
Osteonecrosis of the jaws in n ...... and thalidomide-dexamethasone
@nl
prefLabel
Osteonecrosis of the jaws in n ...... and thalidomide-dexamethasone
@en
Osteonecrosis of the jaws in n ...... and thalidomide-dexamethasone
@nl
P2093
P50
P1433
P1476
Osteonecrosis of the jaws in n ...... and thalidomide-dexamethasone
@en
P2093
Alfonso D'Arco
Claudia Cellini
Delia Cangini
Elena Zamagni
Lucio Catalano
Michela Ceccolini
Michele Baccarani
Paola Tacchetti
Patrizia Tosi
Sante Tura
P304
P356
10.1182/BLOOD-2006-07-033571
P407
P577
2006-12-01T00:00:00Z